Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation
- PMID: 11756336
- DOI: 10.2337/diabetes.51.1.159
Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation
Abstract
Apoptosis has been observed in vascular cells, nerve, and myocardium of diabetic humans and experimental animals, although whether it contributes to or is a marker of complications in these tissues is unclear. Previous studies have shown that incubation of human umbilical vein endothelial cells (HUVECs) with 30 vs. 5 mmol/l glucose for 72 h causes a significant increase in apoptosis, possibly related to an increase in oxidative stress. We report here that this increase in apoptosis (assessed morphologically by TdT-mediated dUTP nick- end labeling staining) is preceded (24 h of incubation) by inhibition of fatty acid oxidation, by increases in diacylglycerol synthesis, the concentration of malonyl CoA, and caspase-3 activity, and by decreases in mitochondrial membrane potential and cellular ATP content. In addition, the phosphorylation of Akt in the presence of 150 microU/ml insulin was impaired. No increases in ceramide content or its de novo synthesis were observed. AMP-activated protein kinase (AMPK) activity was not diminished; however, incubation with the AMPK activator 5-aminoimidazole-4-carboxamide-riboside increased AMPK activity twofold and completely prevented all of these changes. Likewise, expression of a constitutively active AMPK in HUVEC prevented the increase in caspase-3 activity. The results indicate that alterations in fatty-acid metabolism, impaired Akt activation by insulin, and increased caspase-3 activity precede visible evidence of apoptosis in HUVEC incubated in a hyperglycemic medium. They also suggest that AMPK could play an important role in protecting the endothelial cell against the adverse effects of sustained hyperglycemia.
Similar articles
-
Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells.Circ Res. 2001 Jun 22;88(12):1276-82. doi: 10.1161/hh1201.092998. Circ Res. 2001. PMID: 11420304
-
The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells.Biochem Biophys Res Commun. 1999 Nov;265(1):112-5. doi: 10.1006/bbrc.1999.1635. Biochem Biophys Res Commun. 1999. PMID: 10548499
-
Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.Arch Biochem Biophys. 1997 Jan 15;337(2):169-75. doi: 10.1006/abbi.1996.9784. Arch Biochem Biophys. 1997. PMID: 9016810
-
Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity.Endocrinology. 2003 Dec;144(12):5166-71. doi: 10.1210/en.2003-0849. Epub 2003 Sep 18. Endocrinology. 2003. PMID: 14500570 Review.
-
Hyperglycemia and insulin resistance: possible mechanisms.Ann N Y Acad Sci. 2002 Jun;967:43-51. doi: 10.1111/j.1749-6632.2002.tb04262.x. Ann N Y Acad Sci. 2002. PMID: 12079834 Review.
Cited by
-
Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.FASEB J. 2010 Aug;24(8):2620-30. doi: 10.1096/fj.09-152546. Epub 2010 Apr 6. FASEB J. 2010. PMID: 20371623 Free PMC article.
-
Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle.Diabetes. 2010 Oct;59(10):2426-34. doi: 10.2337/db09-1870. Epub 2010 Aug 3. Diabetes. 2010. PMID: 20682696 Free PMC article.
-
Stress signaling in the heart by AMP-activated protein kinase.Curr Hypertens Rep. 2006 Dec;8(6):446-50. doi: 10.1007/s11906-006-0021-z. Curr Hypertens Rep. 2006. PMID: 17087854 Review.
-
Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.Diabetologia. 2004 Nov;47(11):2012-21. doi: 10.1007/s00125-004-1570-9. Epub 2004 Dec 2. Diabetologia. 2004. PMID: 15578153
-
Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension.Int J Mol Sci. 2018 Dec 17;19(12):4081. doi: 10.3390/ijms19124081. Int J Mol Sci. 2018. PMID: 30562953 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials